BRIDGEPOINT GROUP PLC

Ufenau Capital is selling its stake in Altano Group, which specializes in equine medicine, to Bridgepoint, which will become the majority shareholder. Altano is valued at around €600 million in the transaction; the group generates annual revenue of about €350 million and an EBITDA of €50–60 million. For Ufenau, the deal is the largest exit to date from a continuation fund and signals a revival in the M&A segment for SMEs. Bridgepoint plans international expansion—especially in the US and Australia—through add‑on acquisitions and by strengthening specialized treatment segments. » More on handelsblatt.com

Bridgepoint has published a circular on the announced takeover of Kayne Anderson Real Estate and has convened a general meeting for 1 October 2026 at 13:00 in London. Electronic versions of the circular and the proxy form are available on Bridgepoint’s website and have been filed with the Financial Conduct Authority. Bridgepoint gave no details on the financial terms or any further aspects of the takeover in the announcement. » More on de.investing.com

Bridgepoint has announced the issuance of 10,132,073 ordinary shares to satisfy allocation claims related to the takeover of Energy Capital Partners. The new shares will be issued to eligible employees, rank pari passu with existing ordinary shares, and admission to trading on the London Stock Exchange’s main market is expected. After the issuance, the issued share capital will be 891,860,660 voting ordinary shares; in addition, 102,239,292 Operating Partnership units exist that are convertible into ordinary shares but are not part of the issued share capital. » More on de.investing.com